Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving paclitaxel together with irinotecan
works in treating patients with advanced non-small cell lung cancer.